Glenoid Resurfacing System and Method
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application 61/170,290, filed Apr 17, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,662,126 | Glenoid Resurfacing System and Method In force · High confidence | Arthrosurface Incorporated | In force | High confidence | ||
| US 10,478,200 | Glenoid Resurfacing System and Method In force · High confidence | Arthrosurface Incorporated | In force | High confidence | ||
| US 12,185,954 | Glenoid Resurfacing System and Method In force · High confidence | Arthrosurface Incorporated | In force | High confidence | ||
| US 12,778,602 | Glenoid Resurfacing System and Method In force · High confidence | Arthrosurface Incorporated | In force | High confidence | ||
| US 12,193,687 | Glenoid Repair System and Methods of Use Thereof In force · High confidence | Arthrosurface Incorporated | In force | High confidence | ||
| US 11,478,259 | Glenoid Resurfacing System and Method In force · High confidence | Arthrosurface, Incorporated | In force | High confidence | ||
| US 10,945,743 | Glenoid Repair System and Methods of Use Thereof In force · High confidence | Arthrosurface Incorporated | In force | High confidence |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.